Ellis Investment Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-54
Closed -$26K – 427
2022
Q3
$26K Hold
54
– – 0.01% 458
2022
Q2
$25K Hold
54
– – 0.01% 476
2022
Q1
$23K Sell
54
-30
-36% -$12.5K 0.01% 507
2021
Q4
$39K Hold
84
– – 0.01% 453
2021
Q3
$32K Sell
84
-15
-15% -$6.37K 0.01% 450
2021
Q2
$44K Hold
99
– – 0.01% 412
2021
Q1
$42K Sell
99
-476
-83% -$190K 0.01% 407
2020
Q4
$236K Buy
575
+5
+0.9% +$2.08K 0.07% 168
2020
Q3
$236K Buy
570
+6
+1% +$2.41K 0.08% 153
2020
Q2
$220K Buy
564
+545
+2,868% +$204K 0.08% 151
2020
Q1
$5K Buy
+19
New +$6.41K ﹤0.01% 569

Other funds holding HUM

Ellis Investment Partners's HUM Position: Q4 2022 in Review

Ellis Investment Partners sold out of Humana (HUM) in Q4 2022, closing a stake of 54 shares — an estimated $26K sold.

Ellis Investment Partners first reported a position in HUM in Q1 2020 and held it in 11 quarters. The position peaked at $236K in Q4 2020. 1,077 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

  • Ellis Investment Partners reported no remaining Humana position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 54 Humana shares in Q4 2022, an estimated $26K.
  • Ellis Investment Partners first reported a position in Humana in Q1 2020 and held it in 11 quarters.
  • Ellis Investment Partners's Humana position peaked at $236K in Q4 2020.
  • 1,077 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.